AGED Diagnostics

San Francisco, United States · Founded 2022 · $700K raised

Employees
1–10
Founded
2022
Business Model
B2B
Total Funding
$700K
Last Round
Pre-SeedAug 2025
Rounds
1

About

AGED (Active Genomes Expressed) Diagnostics is developing accurate, non-invasive blood tests for the early detection and staging of liver disease. Its genomics-based assays detect circulating genetic signatures associated with conditions such as fibrosis and steatohepatitis (NASH) and liver cancer, aiming to give clinicians an earlier, more affordable alternative to biopsy and current screening methods so patients can access intervention sooner.

Summary

AGED Diagnostics is a Medtech company based in San Francisco, United States, founded in 2022. It has raised $700K in total across 1 round, most recently a Pre-Seed round in Aug 2025. Investors include TEDCO, Plug and Play and Central Texas Angel Network.

Tech & App Stack

2 technologies & apps tracked

Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.

Sign up to view funding chart

Create a free account to see funding visualizations and detailed round data.

Funding History

Investors

Similar Companies